BioSpace News Archive

Drug Development

Eisai Presents Data To Assess Seizure Freedom With FYCOMPA® Monotherapy In Newly Diagnosed Or Untreated Patients With Partial Onset Seizures

Eisai Inc. announced results from its FREEDOM Study, a Phase III open-label study conducted in Japan and South Korea evaluating the efficacy and safety of FYCOMPA® CIII as monotherapy in new onset or untreated patients with partial-onset seizures.

June 25, 2019
·
14 min read
Sobi Presents Study Data Supporting Increased Possibilities and Improved Clinical Outcomes for People With Haemophilia at ISTH

It will be the first time interim results from the global, prospective verITI-8 study of rFVIIIFc for first-time ITI will be presented.

June 25, 2019
·
7 min read
Business

Humana Collaborates with Aspen RxHealth to Offer New App to Connect Patients and Pharmacists

Aspen RxHealth’s platform connects patients to community pharmacists, optimizing patient interactions

June 25, 2019
·
3 min read
Biotech Bay

Vancouver Clinic Improves Patient Care and Embraces IoT With Aruba’s Mobile-First Network

Washington Healthcare Provider Opens its First Neighborhood Clinic in Partnership with Humana to Deliver Enhanced Patient Services using Mobile Technology

June 25, 2019
·
4 min read
Pharm Country

IQVIA Introduces Patient Centered Endpoints Solution with Transformative eCOA Technology Platform

Disruptive tech simplifies patient engagement and amplifies patients’ voices to advance outcomes for life science companies

June 25, 2019
·
4 min read
Deals

Velan Releases Presentation Reiterating the Facts and Setting The Record Straight for Progenics Pharmaceuticals’ Stockholders

Highlights How the Board is Distorting the Truth, Mischaracterizing the Company’s Current Dire State and Misleading Stockholders in an Attempt to Preserve the Troubling Status Quo

June 25, 2019
·
2 min read
Business

EarlySense Adds Healthcare Technology and Informatics Leader Stephen Kahane, M.D., M.S., to Its Board of Directors

EarlySense Continues to Add US-Based Expertise to its Global Leadership

June 25, 2019
·
2 min read
Biotech Beach

Cordlife to Use the ThermoGenesis AXP® II System for Rapid Processing of Cord Blood Units in India

ThermoGenesis Corp. announced that it has entered into a strategic agreement with Cordlife Group Limited to provide its proprietary, next-generation AXP® II System, for the rapid processing of cord blood units, to Cordlife’s India processing facility.

June 25, 2019
·
3 min read
Drug Development

World-renowned Fungal Infection Expert Comments on Oral Ibrexafungerp Data Presented by SCYNEXIS at ASM Microbe 2019

SCYNEXIS, Inc. announced the availability of nine presentations (here) from the American Society for Microbiology (ASM) Microbe 2019, which occurred June 20-24, 2019, in San Francisco.

June 25, 2019
·
8 min read
Drug Development

Imbrium Therapeutics Advances Insomnia Pipeline Through Initiation of a Phase 2 Study of Potential First-in-Class Molecule for Insomnia Associated with Alcohol Cessation

Latest research on drug safety supports continued development of novel small molecule, IMB-115

June 25, 2019
·
6 min read